Related Experiment Video
Updated: Jul 5, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country
1Department of Postgraduate Education and Research, Children's Hospital Dr. Ovidio Aliaga U, La Paz, Bolivia. dr.ariel.salas@gmail.com
Insights
Extreme hyperbilirubinemia in infants is often linked to dehydration and weight loss, particularly in breastfed newborns. Early identification of acute bilirubin encephalopathy (ABE) is crucial for preventing severe kernicteric sequelae.
Area of Science:
- Neonatal Medicine
- Pediatric Gastroenterology
- Clinical Epidemiology
Background:
- Extreme hyperbilirubinemia in infants poses significant health risks, including potential neurological damage.
- Exchange transfusion (ET) is a critical intervention for severe cases of jaundice.
- Understanding the clinical and epidemiological features of infants requiring ET is essential for targeted management.
Purpose of the Study:
- To investigate the clinical and epidemiological characteristics of infants with extreme hyperbilirubinemia necessitating exchange transfusion (ET).
Main Methods:
- A retrospective study included term and near-term infants under 30 days old admitted with total serum bilirubin (TSB) levels ≥428 µmol/L (≥25 mg/dL) requiring ET.
- Data were collected over a 5-year period in La Paz, Bolivia.
Main Results:
- Fifty-six infants were analyzed; 98.2% were exclusively breastfed.
- Over one-third experienced >12% weight loss and dehydration.
- Increased enterohepatic circulation (EHC) was the primary cause (73%).
- Fifteen infants (26.8%) presented with acute bilirubin encephalopathy (ABE); early ABE was reversible, but advanced ABE led to severe sequelae.
Conclusions:
- Dehydration and weight loss in breastfed infants are key factors associated with extreme hyperbilirubinemia and potential brain damage.
- Prompt recognition of ABE signs and appropriate follow-up programs can help prevent severe outcomes.
Objective:
To determine the clinical and epidemiological features of infants with extreme hyperbilirubinemia who require exchange transfusion (ET).
Study Design:
Term and near-term infants admitted to a paediatric hospital over a 5-year period in La Paz, Bolivia, were included in the study if they met the following criteria: age less than 30 days; total serum bilirubin (TSB) levels > or =428 micromol/L (> or =25 mg/dL) on admission and if they had undergone an ET.
Results:
Fifty-six infants were identified during the study period. Most of them were exclusively breastfed (98.2%). Median age at admission was 7 days. Weight loss of more than 12% since birth, as well as dehydration, was registered in more than one-third of cases. Extreme hyperbilirubinemia was considered as secondary to increased enterohepatic circulation (EHC) in most cases (73%). The mean TSB level on admission was 531.8 micromol/L (31.1 mg/dL). Fifteen infants (26.8%) showed signs of acute bilirubin encephalopathy (ABE). Early ABE was reversible after ET in most cases but all infants with advanced ABE developed severe kernicteric sequelae. Nine patients (16.1%) developed adverse events attributable to ET.
Conclusions:
Dehydration and weight loss in breastfed infants appeared to be an important factor associated with extreme hyperbilirubinemia and secondary brain damage during the first week of life. This may well be avoided if signs of ABE and its associated conditions are identified appropriately by follow-up programmes.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Jaundice
Kidney Transplant I: Introduction
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

